Abiopharma

New Form 425 - NLS Pharmaceutics Ltd. Filed: 2025-06-06 AccNo: 0001213900-25-052102 Size: 58 KB

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - MYRIAD GENETICS INC Filed: 2025-06-06 AccNo: 0001628280-25-029977 Size: 4 KB

New Form 4 - Beam Therapeutics Inc. Filed: 2025-06-06 AccNo: 0000950170-25-083051 Size: 5 KB

New Form 8-K - INVO Fertility, Inc. Filed: 2025-06-06 AccNo: 0001641172-25-014019 Size: 329 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits

New Form 4 - Kura Oncology, Inc. Filed: 2025-06-06 AccNo: 0000950170-25-083041 Size: 5 KB

New Form 4 - IOVANCE BIOTHERAPEUTICS, INC. Filed: 2025-06-06 AccNo: 0001104659-25-057310 Size: 5 KB

New Form 4 - Generation Bio Co. Filed: 2025-06-06 AccNo: 0001415889-25-015961 Size: 5 KB

New Form 4 - Generation Bio Co. Filed: 2025-06-06 AccNo: 0001415889-25-015962 Size: 5 KB

New Form 4 - Beam Therapeutics Inc. Filed: 2025-06-06 AccNo: 0000950170-25-083054 Size: 5 KB

New Form 4 - Beam Therapeutics Inc. Filed: 2025-06-06 AccNo: 0000950170-25-083055 Size: 5 KB

New Form 4 - Generation Bio Co. Filed: 2025-06-06 AccNo: 0001415889-25-015958 Size: 5 KB

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - Kura Oncology, Inc. Filed: 2025-06-06 AccNo: 0000950170-25-083039 Size: 5 KB

New Form DEFA14A - SPRUCE BIOSCIENCES, INC. Filed: 2025-06-06 AccNo: 0000950170-25-083045 Size: 2 MB